Records containing: Prurigo Nodularis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-07-10A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2024-07-10A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2024-04-01Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis: a Prospective, Observational Pilot Study
-
CLINICAL_TRIALS study record update · 2023-08-14A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Single Dose Study to Assess the Safety, Pharmacokinetics, and Clinical Effect of CDX-0159 in Patients With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2023-07-03Efficacy, Safety, and Tolerability of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-03-11The Use of Local Anesthetic in Intralesional Corticosteroid Injections; A Randomized, Double Blind Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-02-09Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing
-
CLINICAL_TRIALS study record update · 2021-02-02A Randomized, Double-Blind, Placebo-Controlled, Study of Neurokinin-1 Receptor Antagonist Serlopitant in Subjects With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2020-11-30An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus
-
CLINICAL_TRIALS study record update · 2020-10-28A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2020-10-23An Open Label Extension Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Prurigo Nodularis Patients
-
CLINICAL_TRIALS study record update · 2020-09-07A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2020-08-21A Randomized, Double-Blind, Placebo-Controlled, Parallel, 3-Arm Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Prurigo Nodularis Patients
-
CLINICAL_TRIALS study record update · 2020-02-19A Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis (PN)
-
CLINICAL_TRIALS study record update · 2018-07-03Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2014-06-20An Open Label, Single Center Study to Assess the Safety and Efficacy of a 24 Week Treatment Course of CC-10004 in Adults With Recalcitrant Nodularis
-
CLINICAL_TRIALS study record update · 2010-07-07Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease
-
CLINICAL_TRIALS study record update · 2007-09-20ClinicalTrials.gov study NCT00532519